PRODUCTS / Papix / Papix high Purifying gel

PapiX™ high Purifying gel

ACNEIC AND ACNE PRONE SKIN

Help your patients regain their confidence with a clinically proven effective 1st line treatment option.

PapiXTM high

Purifying gel 2

PapiXTM high helps reduce seborrhea production and improve acneic lesions within 30 days of use3

MEDICAL DEVICE

products_papix_high

Salicylic acid 3

Urea peroxide 3

Zinc gluconate 3

Taurine 3

brakets03

Formulated without silicons, vegetable or mineral oils and petroleum jelly which could increase sebum production3

brakets04

PROVEN EFFICACY IN INDUCING SIGNIFICANT IMPROVEMENT IN ACNE LESIONS OVER 30 DAYS OF TREATMENT 1+

Global Clinical Impressions score after 30 days of using 3 PapiXTM products in combination

Evidence of efficacy in 90% of the cases

papix_01
PapiX™ Range
ACNEIC AND ACNE PRONE SKIN

significant improvement in acne lesions WITH high tolerability and pleasantness of use1

papix_check

Dermatologically tested3,4,5

Not photosensitising3,4

Non comedogenic5

Help your patients regain their confidence with a clinically proven effective 1st line treatment option.

+Clinical observational study conducted on 200 volunteers, both male and female, who were suffering from mild to moderate facial acne. The study protocol included two observational levels: T0 and T1 (30 days of treatment). Efficacy was measured according to the Global Acne Grading System (GAGS). The safety and acceptability were evaluated using a Global Clinical Impressions score (the Investigator Global Assessment: IGA) performed at T1 (after 30 days of treatment). The IGA score was rated as follows: 0 = no improvement, 1 = moderate improvement, 2 = marked improvement, 3 = clear-cut improvement/disappearance of baseline lesion/condition. Regarding pleasantness and ease of application, at T1 the volunteers were asked to give their impressions using a semi-quantitative score (Poor, Sufficient, Fair, Good and Excellent). In 76% of the volunteers treated during this study, no associated systemic therapy was administered while 14% received oral antibiotics and 3.5% estroprogestinics.

  1. Rigoni C et al. Clinical observational study of the topical treatment of mild to moderate acne. J Plastic Dermatology 2016; 12: 1-5.
  2. PapiX high labelling
  3. PapiX high PIL
  4. PapiX long PIL
  5. PapiX cleanser labelling
Scroll to Top